{
    "root": "0aca9c58-9720-420b-a0fa-3ef6c841f35c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Heparin Sodium",
    "value": "20250415",
    "ingredients": [
        {
            "name": "HEPARIN SODIUM",
            "code": "ZZ45AB24CA",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_230519"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26710"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17987"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        }
    ],
    "indications": {
        "text": "heparin sodium injection indicated : \u2022prophylaxis treatment venous thrombosis pulmonary embolism ; \u2022prevention postoperative deep venous thrombosis pulmonary embolism patients undergoing major abdominothoracic surgery , reasons , risk developing thromboembolic disease ; \u2022atrial fibrillation embolization ; \u2022treatment acute chronic consumptive coagulopathies ( disseminated intravascular coagulation ) ; \u2022prevention clotting arterial cardiac surgery ; \u2022prophylaxis treatment peripheral arterial embolism . \u2022anticoagulant blood transfusions , extracorporeal circulation , dialysis procedures .",
        "doid_entities": [
            {
                "text": "thrombosis (DOID:0060903)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0060903"
            },
            {
                "text": "pulmonary embolism (DOID:9477)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9477"
            },
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            },
            {
                "text": "disseminated intravascular coagulation (DOID:11247)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11247"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended adult dosages : \u2022 therapeutic anticoagulant effect full-dose heparin \u2020 ( 2.4 ) deep subcutaneous ( intrafat ) injection different site injection initial dose 5,000 units intravenous injection , followed 10,000 20,000 units concentrated solution , subcutaneously every 8 hours every 12 hours 8,000 10,000 units concentrated solution 15,000 20,000 units concentrated solution intermittent intravenous injection initial dose 10,000 units , either undiluted 50 100 ml 0.9 % sodium chloride injection , usp every 4 6 hours 5,000 10,000 units , either undiluted 50 100 ml 0.9 % sodium chloride injection , usp intravenous infusion initial dose 5,000 units intravenous injection continuous 20,000 40,000 units/24 hours 1000 ml 0.9 % sodium chloride injection , usp ( compatible solution ) infusion \u2020 based 150 lb ( 68 kg ) patient . adjust dose based laboratory monitoring .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "heparin sodium injection , usp preserved benzyl alcohol clear solution available following strengths package sizes single-dose vials : description ndc 1,000 usp units per ml ( 1 ml-fill ) 25 vials : 1,000 usp units per ml , single-dose * 67457-372-99 5,000 usp units per ml ( 1 ml-fill ) 25 vials : 5,000 usp units per ml , single-dose * 67457-374-99 10,000 usp units per ml ( 1 ml-fill ) 25 vials : 10,000 usp units per ml , single-dose * 67457-602-99 * discard unused portion heparin sodium injection , usp preserved benzyl alcohol clear solutionis available following strengths package sizes multiple-dose vials : description ndc 1,000 usp units per ml ( 10 ml-fill ) 25 vials : 10,000 usp units per 10 ml , multiple-dose 67457-385-99 1,000 usp units per ml ( 30 ml-fill ) 25 vials : 30,000 usp units per 30 ml , multiple-dose 67457-384-99 5,000 usp units per ml ( 10 ml-fill ) 25 vials : 50,000 usp units per 10 ml , multiple-dose 67457-383-99 10,000 usp units per ml ( 4 ml-fill ) 25 vials : 40,000 usp units per 4 ml , multiple-dose 67457-603-99 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) . [ usp controlled room temperature . ]",
    "adverseReactions": "heparin sodium injection contraindicated patients following conditions : \u2022history heparin-induced thrombocytopenia heparin-induced thrombocytopenia thrombosis [ ( 5.3 ) ] ; \u2022known hypersensitivity heparin pork products ( e.g . , anaphylactoid ) [ ( 6.1 ) ] ; \u2022in suitable blood coagulation tests , e.g . , whole blood clotting time , partial thromboplastin time , etc . , performed appropriate intervals ( contraindication refers full-dose heparin ; usually need monitor coagulation parameters patients receiving low-dose heparin ) ; \u2022an uncontrolled active bleeding state [ ( 5.2 ) ] , except due disseminated intravascular coagulation .",
    "indications_original": "Heparin sodium injection is indicated for: \n                  \n                     \n                        \u2022Prophylaxis and treatment of venous thrombosis and pulmonary embolism; \n                     \n                        \u2022Prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; \n                     \n                        \u2022Atrial fibrillation with embolization; \n                     \n                        \u2022Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); \n                     \n                        \u2022Prevention of clotting in arterial and cardiac surgery; \n                     \n                        \u2022Prophylaxis and treatment of peripheral arterial embolism. \n                     \n                        \u2022Anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures.",
    "contraindications_original": "Recommended Adult Dosages: \u2022 Therapeutic Anticoagulant Effect with Full-Dose Heparin \u2020 ( 2.4 ) Deep Subcutaneous (Intrafat) Injection Use a different site for each injection Initial Dose 5,000 units by intravenous injection, followed by 10,000 to 20,000 units of a concentrated solution, subcutaneously Every 8 hours or Every 12 hours 8,000 to 10,000 units of a concentrated solution 15,000 to 20,000 units of a concentrated solution Intermittent Intravenous Injection Initial dose 10,000 units, either undiluted or in 50 to 100\u00a0mL of 0.9% Sodium Chloride Injection, USP Every 4 to 6 hours 5,000 to 10,000 units, either undiluted or in 50 to 100 mL of 0.9% Sodium Chloride Injection, USP Intravenous Infusion Initial dose 5,000 units by intravenous injection Continuous 20,000 to 40,000 units/24 hours in 1000 mL of 0.9% Sodium Chloride Injection, USP (or in any compatible solution) for infusion \u2020 Based on 150 lb (68 kg) patient. Adjust dose based on laboratory monitoring.",
    "warningsAndPrecautions_original": "Heparin Sodium Injection, USP preserved with benzyl alcohol clear solution is available in the following strengths and package sizes in single-dose vials:\n                  \n                     \n                     \n                     \n                        \n                           \n                              \n                                 DESCRIPTION \n                              \n                           \n                           \n                              \n                                 NDC \n                              \n                           \n                        \n                        \n                           \n                              \n                                 1,000 USP units per mL (1 mL-fill)\n                              \n                           \n                        \n                        \n                           \n                              \u00a0\u00a0\u00a0\u00a025 vials: 1,000 USP units per mL, single-dose*\n                           \n                           \n                              \n                                 67457-372-99\n                              \n                           \n                        \n                        \n                           \n                              \n                                 5,000 USP units per mL (1 mL-fill)\n                              \n                           \n                        \n                        \n                           \n                              \u00a0\u00a0\u00a0\u00a025 vials: 5,000 USP units per mL, single-dose* \n                           \n                           \n                              \n                                 67457-374-99 \n                              \n                           \n                        \n                        \n                           \n                              \n                                 10,000 USP units per mL (1 mL-fill)\n                              \n                           \n                        \n                        \n                           \n                              \u00a0\u00a0\u00a0\u00a025 vials: 10,000 USP units per mL, single-dose*\n                           \n                           \n                              \n                                 67457-602-99 \n                              \n                           \n                        \n                     \n                  \n                  \n                     *Discard unused portion\n                  Heparin Sodium Injection, USP preserved with benzyl alcohol clear solutionis available in the following strengths and package sizes in multiple-dose vials: \n                  \n                     \n                     \n                     \n                        \n                           \n                              \n                                 DESCRIPTION \n                              \n                           \n                           \n                              \n                                 NDC \n                              \n                           \n                        \n                        \n                           \n                              \n                                 1,000 USP units per mL (10 mL-fill)\n                              \n                           \n                        \n                        \n                           \n                              \u00a0\u00a0\u00a0\u00a025 vials: 10,000 USP units per 10 mL, multiple-dose \n                           \n                           \n                              \n                                 67457-385-99\n                              \n                           \n                        \n                        \n                           \n                              \n                                 1,000 USP units per mL (30 mL-fill)\n                              \n                           \n                        \n                        \n                           \n                              \u00a0\u00a0\u00a0\u00a025 vials: 30,000 USP units per 30 mL, multiple-dose \n                           \n                           \n                              \n                                 67457-384-99 \n                              \n                           \n                        \n                        \n                           \n                              \n                                 5,000 USP units per mL (10 mL-fill)\n                              \n                           \n                        \n                        \n                           \n                              \u00a0\u00a0\u00a0\u00a025 vials: 50,000 USP units per 10 mL, multiple-dose \n                           \n                           \n                              \n                                 67457-383-99 \n                              \n                           \n                        \n                        \n                           \n                              \n                                 10,000 USP units per mL (4 mL-fill)\n                              \n                           \n                        \n                        \n                           \n                              \u00a0\u00a0\u00a0\u00a025 vials: 40,000 USP units per 4 mL, multiple-dose \n                           \n                           \n                              \n                                 67457-603-99 \n                              \n                           \n                        \n                     \n                  \n                  \n                     Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F). [See USP Controlled Room Temperature.]",
    "adverseReactions_original": "The use of heparin sodium injection is contraindicated in patients with the following conditions: \n                  \n                     \n                        \u2022History of heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis [see Warnings and Precautions (5.3)]; \n                     \n                        \u2022Known hypersensitivity to heparin or pork products (e.g., anaphylactoid reactions) [see Adverse Reactions (6.1)]; \n                     \n                     \n                        \u2022In whom suitable blood coagulation tests, e.g., the whole blood clotting time, partial thromboplastin time, etc., cannot be performed at appropriate intervals (this contraindication refers to full-dose heparin; there is usually no need to monitor coagulation parameters in patients receiving low-dose heparin); \n                     \n                        \u2022An uncontrolled active bleeding state [see Warnings and Precautions (5.2)\n                        ], except when this is due to disseminated intravascular coagulation.",
    "drug": [
        {
            "name": "Heparin Sodium",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_230519"
        }
    ]
}